Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
While those with pre-existing conditions like chronic obstructive pulmonary disease (COPD) or asthma are the worst hit, people with no prior medical history are experiencing symptoms like chest ...